EMH
0.38
76.7%
C7A
0.002
-50%
DTM
0.055
66.7%
BOC
0.6
-47.8%
SRL
6.62
56.5%
TR2
0.395
-35.2%
CLE
0.065
54.8%
1TT
0.002
-33.3%
CBE
0.15
53.1%
BLZ
0.002
-33.3%
BIT
0.003
50%
LNU
0.002
-33.3%
EXR
0.063
50%
M2M
0.012
-29.4%
M2R
0.003
50%
MGU
0.005
-28.6%
TGN
0.225
50%
EZZ
1.7
-28.1%
MTM
1.02
48.9%
VMM
0.98
-26.9%
TNC
0.605
47.6%
PGY
0.003
-25%
AUR
0.023
43.8%
KOB
0.055
-23.6%
SRJ
0.017
41.7%
FMR
0.26
-21.2%
ZNC
0.115
40.2%
BOA
0.027
-20.6%
AEU
0.335
39.6%
AUG
0.035
-20.5%
EQR
0.064
39.1%
OEL
0.004
-20%
SKM
0.285
39%
VEN
0.004
-20%
DGR
0.025
38.9%
OCT
0.037
-19.6%
HIQ
0.025
38.9%
L1M
0.031
-18.4%
PTX
0.074
37%
DKM
0.14
-17.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Imricor Medical Systems (ASX: IMR): Awarded CE mark approval

Developer of MRI-compatible devices, Imricor Medical Systems (ASX: IMR) has been awarded CE mark certification from the EU for its Vision-MR Diagnostic Catheter, allowing for manufacturing and release into the clinical market | ASX announcement: https://announcements.asx.com.au/asxpdf/20240306/pdf/0616gfxf12g8pc.pdf